WETS
VKTX icon

Wealth Enhancement Trust Services’s Viking Therapeutics VKTX Stock Holding History

Wealth Enhancement Trust Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28K Buy
+84
New +$2.71K ﹤0.01% 921

Other funds holding VKTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealth Enhancement Trust Services's VKTX Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 84 shares worth $3.28K. The stake represents ﹤0.01% of the portfolio and ranks #921 among its holdings.

309 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Wealth Enhancement Trust Services held 84 shares of Viking Therapeutics worth $3.28K as of Q2 2026.
  • Viking Therapeutics was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #921 holding.
  • 309 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.